|
1
|
Karnak D and Xu L: Chemosensitization of
prostate cancer by modulating Bcl-2 family proteins. Curr Drug
Targets. 11:699–707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gul O, Basaga H and Kutuk O: Apoptotic
blocks and chemotherapy resistance: strategies to identify Bcl-2
protein signatures. Brief Funct Genomic Proteomic. 7:27–34. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu JR, Opipari AW, Tan L, Jiang Y, Zhang
Y, Tang H and Nuñez G: Dysfunctional apoptosome activation in
ovarian cancer: implications for chemoresistance. Cancer Res.
62:924–931. 2002.PubMed/NCBI
|
|
4
|
Klymenko T, Brandenburg M, Morrow C, Dive
C and Makin G: The novel Bcl-2 inhibitor ABT-737 is more effective
in hypoxia and is able to reverse hypoxia-induced drug resistance
in neuroblastoma cells. Mol Cancer Ther. 10:2373–2383. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang L, Ming L and Yu J: BH3 mimetics to
improve cancer therapy: mechanisms and examples. Drug Resist Updat.
10:207–217. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kang MH and Reynolds CP: Bcl-2 inhibitors:
targeting mitochondrial apoptotic pathways in cancer therapy. Clin
Cancer Res. 15:1126–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Premkumar DR, Jane EP, DiDomenico JD,
Vukmer NA, Agostino NR and Pollack IF: ABT-737 synergizes with
bortezomib to induce apoptosis, mediated by Bid cleavage, Bax
activation, and mitochondrial dysfunction in an Akt-dependent
context in malignant human glioma cell lines. J Pharmacol Exp Ther.
341:859–872. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Olberding KE, White C and Li C:
Bcl-2 proteins regulate ER membrane permeability to luminal
proteins during ER stress-induced apoptosis. Cell Death Differ.
18:38–47. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhavya BC, Indira D, Seervi M, Joseph J,
Sobhan PK, Mathew KA, Varghese S and Santhoshkumar TR: Endoplasmic
reticulum-targeted Bcl-2 inhibitable mitochondrial fragmentation
initiates ER stress-induced cell death. Adv Exp Med Biol.
749:83–95. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dasmahapatra G, Lembersky D, Rahmani M,
Kramer L, Friedberg J, Fisher RI, Dent P and Grant S: Bcl-2
antagonists interact synergistically with bortezomib in DLBCL cells
in association with JNK activation and induction of ER stress.
Cancer Biol Ther. 8:808–819. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Szegezdi E, Macdonald DC, Ní Chonghaile T,
Gupta S and Samali A: Bcl-2 family on guard at the ER. Am J Physiol
Cell Physiol. 296:C941–C953. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou F, Yang Y and Xing D: Bcl-2 and
Bcl-xL play important roles in the crosstalk between autophagy and
apoptosis. FEBS J. 278:403–413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marquez RT and Xu L: Bcl-2: Beclin 1
complex: multiple, mechanisms regulating autophagy/apoptosis toggle
switch. Am J Cancer Res. 2:214–221. 2012.PubMed/NCBI
|
|
14
|
Lian J, Wu X, He F, Karnak D, Tang W, Meng
Y, Xiang D, Ji M, Lawrence TS and Xu L: A natural BH3 mimetic
induces autophagy in apoptosis-resistant prostate cancer via
modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell
Death Differ. 18:60–71. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu Y, Yu H, Qin H, Kang J, Yu C, Zhong J,
Su J, Li H and Sun L: Inhibition of autophagy enhances cisplatin
cytotoxicity through endoplasmic reticulum stress in human cervical
cancer cells. Cancer Lett. 314:232–243. 2011. View Article : Google Scholar
|
|
16
|
Shi YH, Ding ZB, Zhou J, Hui B, Shi GM, Ke
AW, Wang XY, Dai Z, Peng YF, Gu CY, Qiu SJ and Fan J: Targeting
autophagy enhances sorafenib lethality for hepatocellular carcinoma
via ER stress-related apoptosis. Autophagy. 7:1159–1172. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Z, Song T, Zhang T, Gao J, Wu G, An
L and Du G: A novel BH3 mimetic S1 potently induces
Bax/Bak-dependent apoptosis by targeting both Bcl-2 and Mcl-1. Int
J Cancer. 128:1724–1735. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Z, Wu G, Gao J and Song T: Inclusion
complex of a Bcl-2 inhibitor with cyclodextrin: characterization,
cellular accumulation, and in vivo antitumor activity. Mol Pharm.
7:1348–1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Z, Wu G, Xie F, Song T and Chang X:
3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile
(S1) based molecules as potent, dual inhibitors of B-cell lymphoma
2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1):
structure-based design and structure-activity relationship studies.
J Med Chem. 54:1101–1105. 2011.
|
|
20
|
Zhong JT, Xu Y, Yi HW, Su J, Yu HM, Xiang
XY, Li XN, Zhang ZC and Sun LK: The BH3 mimetic S1 induces
autophagy through ER stress and disruption of Bcl-2/Beclin 1
interaction in human glioma U251 cells. Cancer Lett. 323:180–187.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muller C, Bandemer J, Vindis C, Camaré C,
Mucher E, Guéraud F, Larroque-Cardoso P, Bernis C, Auge N, Salvayre
R and Negre-Salvayre A: Protein Disulfide Isomerase Modification
and Inhibition potentiates ER stress and apoptosis induced by
oxidized low density lipoproteins. Antioxid Redox Signal.
18:731–742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee AS: The glucose-regulated proteins:
stress induction and clinical applications. Trends Biochem Sci.
26:504–510. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miller SD, Greene CM, McLean C, Lawless
MW, Taggart CC, O’Neill SJ and McElvaney NG: Tauroursodeoxycholic
acid inhibits apoptosis induced by Z alpha-1 antitrypsin via
inhibition of bad. Hepatology. 46:496–503. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang JY, Diao YF, Kim HR and Jin DI:
Inhibition of endoplasmic reticulum stress improves mouse embryo
development. PLoS One. 7:e404332012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakagawa T, Zhu H, Morishima N, Li E, Xu
J, Yankner BA and Yuan J: Caspase-12 mediates
endoplasmic-reticulum-specific apoptosis and cytotoxicity by
amyloid-β. Nature. 403:98–103. 2000.PubMed/NCBI
|
|
26
|
Binet F, Chiasson S and Girard D: Evidence
that endoplasmic reticulum (ER) stress and caspase-4 activation
occur in human neutrophils. Biochem Biophys Res Commun. 391:18–23.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mao ZG, Jiang CC, Yang F, Thorne RF,
Hersey P and Zhang XD: TRAIL-induced apoptosis of human melanoma
cells involves activation of caspase-4. Apoptosis. 15:1211–1222.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Verfaillie T, Salazar M, Velasco G and
Agostinis P: Linking ER stress to autophagy: potential implications
for cancer therapy. Int J Cell Biol. 2010:9305092010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eliopoulos AG, Kerr DJ, Herod J, Hodgkins
L, Krajewski S, Reed JC and Young LS: The control of apoptosis and
drug resistance in ovarian cancer: influence of p53 and Bcl-2.
Oncogene. 11:1217–1228. 1995.PubMed/NCBI
|
|
30
|
Mano Y, Kikuchi Y, Yamamoto K, Kita T,
Hirata J, Tode T, Ishii K and Nagata I: Bcl-2 as a predictor of
chemosensitivity and prognosis in primary epithelial ovarian
cancer. Eur J Cancer. 35:1214–1219. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van Delft MF and Huang DC: How the Bcl-2
family of proteins interact to regulate apoptosis. Cell Res.
16:203–213. 2006.PubMed/NCBI
|
|
32
|
Simonian PL, Grillot DA and Nuñez G: Bcl-2
and Bcl-XL can differentially block chemotherapy-induced cell
death. Blood. 90:1208–1216. 1997.PubMed/NCBI
|
|
33
|
Reed JC, Miyashita T, Takayama S, Wang HG,
Sato T, Krajewski S, Aimé-Sempé C, Bodrug S, Kitada S and Hanada M:
BCL-2 family proteins: regulators of cell death involved in the
pathogenesis of cancer and resistance to therapy. J Cell Biochem.
60:23–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schönthal AH: Endoplasmic reticulum stress
and autophagy as targets for cancer therapy. Cancer Lett.
275:163–169. 2009.PubMed/NCBI
|
|
35
|
Schönthal AH: Pharmacological targeting of
endoplasmic reticulum stress signaling in cancer. Biochem
Pharmacol. 85:653–666. 2013.PubMed/NCBI
|
|
36
|
Zhang YX, Kong CZ, Wang LH, Li JY, Liu XK,
Xu B, Xu CL and Sun YH: Ursolic acid overcomes Bcl-2-mediated
resistance to apoptosis in prostate cancer cells involving
activation of JNK-induced Bcl-2 phosphorylation and degradation. J
Cell Biochem. 109:764–777. 2010.PubMed/NCBI
|
|
37
|
Shimizu S, Konishi A, Nishida Y, Mizuta T,
Nishina H, Yamamoto A and Tsujimoto Y: Involvement of JNK in the
regulation of autophagic cell death. Oncogene. 29:2070–2082. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: a
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu H, Su J, Xu Y, Kang J, Li H, Zhang L,
Yi H, Xiang X, Liu F and Sun L: p62/SQSTM1 involved in cisplatin
resistance in human ovarian cancer cells by clearing ubiquitinated
proteins. Eur J Cancer. 47:1585–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sirichanchuen B, Pengsuparp T and
Chanvorachote P: Long-term cisplatin exposure impairs autophagy and
causes cisplatin resistance in human lung cancer cells. Mol Cell
Biochem. 364:11–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Suh DH, Kim MK, Kim HS, Chung HH and Song
YS: Unfolded protein response to autophagy as a promising druggable
target for anticancer therapy. Ann NY Acad Sci. 1271:20–32. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zeng R, He J, Peng J, Chen Y, Yi S, Zhao F
and Cui G: The time-dependent autophagy protects against apoptosis
with possible involvement of Sirt1 protein in multiple myeloma
under nutrient depletion. Ann Hematol. 91:407–417. 2011. View Article : Google Scholar : PubMed/NCBI
|
